Botox maker announces profits
|February 4, 2011||Posted by George Chapple under News|
According to bloomberg.com, Botox manufacturer Allergan Inc. announced on Wednesday their profits grew by 19 per cent in the fourth quarter of 2010. The growth is due to strong sales of the anti-wrinkle treatment Botox.
The company’s profits have risen to $263.1 million, compared with $221.5 million recorded 12 months ago.
Allergan announced sales of speciality drugs had increased by 7 per cent to $1.06 billion in the fourth quarter, whilst Botox sales grew by 11 per cent to $386.2 million. Botox is a now a world renown anti-wrinkle solution, but the toxin is also used as a treatment for headaches and muscle spasms.
Forecasters at Allergan expect 2011 to be a good year for business. If their predictions are correct the overall company revenue will rise from $5.02 billion to $5.22 billion. With demand for anti-ageing treatments on the rise, the Botox turnover is expected to be around $1.54 billion compared with $1.42 billion in 2010.
The latest in Botox news, brought to you by botoxblog.org.